Forget Novocure's Big Drop; Focus on the Long Term

Shares of Novocure (NASDAQ: NVCR) have plunged more than 70% below their highs set last summer. In this Motley Fool Live video recorded on Jan. 19, Motley Fool contributors Keith Speights and Brian Orelli talk about why focusing on the long-term prospects of this healthcare stock is the best move. Keith Speights: Mabel asks, "Can you discuss Novocure's recent drop?" Ticker there is NVCR.